Precision Biosciences (DTIL) Current Leases (2020 - 2026)

Precision Biosciences (DTIL) has 7 years of Current Leases data on file, last reported at $1.6 million in Q1 2026.

• Current Leases for Q1 2026 came in at $1.6 million, up 14.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 14.07% YoY), and the FY2025 annual result was $1.5 million, up 14.17% from the prior year.
• Current Leases climbed to $1.6 million in Q1 2026 per DTIL's latest filing, from $1.5 million in the prior quarter.
• Over five years, Current Leases peaked at $2.5 million in Q2 2023 and troughed at $1.1 million in Q4 2023.
• A 5-year average of $1.6 million and a median of $1.5 million in 2023 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2024: Current Leases advanced 29.68% in 2023, then sank 51.06% in 2024.
• A 5-year view of Current Leases shows it stood at $1.7 million in 2022, then sank by 32.48% to $1.1 million in 2023, then advanced by 16.5% to $1.3 million in 2024, then grew by 14.17% to $1.5 million in 2025, then advanced by 3.32% to $1.6 million in 2026.
• Business Quant data shows DTIL's Current Leases at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.